Status:
RECRUITING
Anterior Cruciate Ligament Study
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
ACL Injury
ACL
Eligibility:
All Genders
18-65 years
Brief Summary
This retrospective, prospective observational study aims to evaluate the epidemiology and rate of anterior cruciate ligament re- rupture after surgery in patients treated from January 2020 to December...
Eligibility Criteria
Inclusion
- \- Males and females- attained skeletal maturity
- 18-65 inclusive
- Patients operated on anterior cruciate ligament reconstruction surgery at the Hospital's Casco unit from 2010 to 2030
- Signature informed consent for patients who will be operated on in the prospective phase (from CE approval date to 2030)
Exclusion
- failure to reach skeletal maturity
- Concomitant ligamentous injuries (pcl, mcl, lcl)
- Neuropsychiatric illness, developmental disorders
- Pregnant women through self-declaration or breastfeeding
- Minors
Key Trial Info
Start Date :
December 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT06194682
Start Date
December 6 2023
End Date
December 31 2030
Last Update
January 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Galeazzi
Milan, Italy, 20100